Patent ductus arteriosus
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Cardiovascular Diseases
|
Congenital Abnormality
|
510
|
56
|
0.200 |
None |
|
0 |
|
|
|
Seizures
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
2152
|
553
|
0.100 |
None |
|
0 |
1
|
|
|
Poor school performance
|
phenotype |
|
Finding
|
211
|
411
|
0.100 |
None |
|
0 |
1
|
|
|
Cardiomegaly
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Finding
|
267
|
11
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Cardiomyopathies
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
925
|
294
|
0.300 |
strong |
1.000 |
1 |
|
2019 |
2019 |
Dilatation of the bladder
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Nervous System Diseases
|
Finding
|
3
|
1
|
0.300 |
strong |
1.000 |
1 |
|
2019 |
2019 |
Cardiac Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
88
|
11
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Cardiomyopathy, Dilated
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
512
|
509
|
0.210 |
None |
1.000 |
1 |
|
2003 |
2003 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Hypertrophic disorder of skin, unspecified
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
62
|
1
|
0.010 |
None |
1.000 |
1 |
|
2006 |
2006 |
Ventricular hypertrophy
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
60
|
9
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Malignant Fibrous Histiocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
150
|
3
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Childhood Leiomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
140
|
1
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Childhood Liposarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
143
|
6
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Adult Leiomyosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
141
|
1
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Fibrosis, Liver
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
1179
|
64
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Varicosity
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
188
|
51
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Adult Liposarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
143
|
6
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Disseminated Malignant Neoplasm
|
phenotype |
Neoplasms
|
Neoplastic Process
|
232
|
4
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Opiate Addiction
|
disease |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
81
|
46
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Secondary Neoplasm
|
group |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2492
|
85
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Nasopharyngeal carcinoma
|
disease |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
1553
|
320
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |